No Detail Found!

Therapeutic effect of levodopa-carbidopa-entacapone combined with rTMS in Parkinson's disease

Author(s)
Ke-fei Zhang Department of Encephalopathy, Huaian Traditional Chinese Medicine Hospital,Huaian, Jiangsu,China
Bing Wang Department of Encephalopathy, Huaian Traditional Chinese Medicine Hospital,Huaian, Jiangsu,China
Qing-yun Yu Department of Encephalopathy, Huaian Traditional Chinese Medicine Hospital,Huaian, Jiangsu,China
Guo-bang Wei Department of Encephalopathy, Huaian Traditional Chinese Medicine Hospital,Huaian, Jiangsu,China
Xiao-rui Cui Department of Rehabilitation, Lianshui Country People's Hospital,Huaian, Jiangsu,China
Li-Ying Zhang Department of Rehabilitation, Lianshui Country People's Hospital,Huaian, Jiangsu,China
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive tissue deterioration. This study evaluated the effects of levodopa-carbidopa-entacapone (LCE) combined with high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) in elderly PD patients. Participants were divided into an observation group (HF-rTMS + LCE) and a control group (HF-rTMS alone). Motor and cognitive function, quality of life, and adverse effects were assessed before treatment and at 8 weeks, 16 weeks, and 6 months post-treatment. Both groups showed no significant differences in baseline data. However, post-treatment, the observation group demonstrated superior clinical improvements. The Unified Parkinson's Disease Rating Scale-III (UPDRS-III) score significantly decreased from 43.40±3.94 to 34.73±5.05 at 6 months (P0.05). These results suggest HF-rTMS combined with LCE enhances motor function, balance, cognition, and quality of life in elderly PD patients without increasing adverse effects,
Publication Details
Page(s) 241-247
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Parkinson's disease, Transcranial magnetic stimulation, Levodopa, carbidopa, entacapone
References
Brunoni AR,Boggio PS .2008 .Can the 'yin and yang' BDNF hypothesis be used to predict the effects of rTMS treatment in neuropsychiatry? Med. , 71(2) : 279-282.
Chen F,Chen S,Si A,Luo Y,Hu W,Zhang Y .2022 .The long-term trend of Parkinson's disease incidence and mortality in China and a Bayesian projection from 2020 to 2030. , 14 : 973310.
Chen X,Xiu H,Hou Y,Chen X,Liu F,Tu S F .2024 .High-frequency repetitive transcranial magnetic stimulation on overall cognition in patients with poststroke cognitive impairment: A systematic review and meta-analysis. Am. J. Phys. Med, 103(5) : 418-427.
Cho SS,Strafella AP .2009 .rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One, 4(8) : e6725.
Fahn S and Elton R,Marsden C,Calne D .1987 .Unified Parkinson's disease rating scale. , 2 : 153-164.
Kamble N,Netravathi M,Pal PK M .2014 .Therapeutic applications of repetitive transcranial magnetic stimulation (rTMS) in movement disorders: A review. Parkinsonism Relat, 20(7) : 695-707.
Karikari TK,Charway-Felli A,Hoglund K,Blennow K,Zetterberg H K .2018 .Front. , 9 : 201.
Karuka AH,Silva JA,Navega MT .2011 .Analysis of agreement of assessment tools of body balance in the elderly. Rev. Bras. Fisioter, 15(6) : 460-466.
King LA,Peterson DS,Mancini M,Carlson-Kuhta P,Fling BW,Smulders K,Nutt JG,Dale M,Carter J,Winters-Stone KM,Horak FB .2015 .Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease: A randomized clinical trial. BMC Neurol, 15 : 218.
Li J,Lou Z,Liu X,Sun Y,Chen J .2017 .Efficacy and safety of adjuvant treatment with entacapone in advanced parkinson's disease with motor fluctuation: A systematic meta-analysis. Eur. Neurol., 78(3-4) : 143-153.
Liao X,Wu N,Liu D,Shuai B,Li S,Li K .2020 .Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: A meta-analysis. Neurol Sci., 41(8) : 2045-2054.
Marras C,Rochon P,Lang AE .2002 .Predicting motor decline and disability in Parkinson disease: A systematic review. Arch. Neurol., 59(11) : 1724-1728.
Michael P,Constantinou Juhasz SB,Evagorou O,Psalta L,Mikellides G .2022 .High-frequency rTMS improves quality of life and depressive symptoms in Parkinson's disease: A case report. Heliyon, 8(12) : e12196.
Muslimovic D,Post B,Speelman JD,Schmand B,de Haan RJ .2008 .Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology, 70(23) : 2241-2247.
Nasreddine ZS,Phillips NA,Bedirian V,Charbonneau S,Whitehead V,Collin I,Cummings JL,Chertkow H JL .2005 .The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc., 53(4) : 695-699.
Pal E,Nagy F,Aschermann Z,Balazs E,Kovacs N E .2010 .The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study. Mov. Disord, 25(14) : 2311-2317.
Peto V,Jenkinson C,Fitzpatrick R,Greenhall R .1995 .The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual. Life Res., 4(3) : 241-248.
Scherfer E,Bohls C,Freiberger E,Heise KF,Hogan DJP .2006 .Berg-Balance-Scale - Deutsche version. , 2(2) : 59-66.
Schrag A,Jahanshahi M,Quinn N M .2000 .How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov, 15(6) : 1112-1118.
Senek M,Nielsen EI,Nyholm D EI .2017 .Levodopaentacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study. Mov. Disord, 32(2) : 283-286.
Thanakamchokchai J,Tretriluxana J,Pakaprot N,Pisarnpong A,Fisher BE .2020 .Effects of highfrequency repetitive transcranial magnetic stimulation on reach-to-grasp performance in individuals with Parkinson's disease: A preliminary study. Exp. Brain Res., 238(9) : 1827-1837.
Wang Y,Ding Y,Guo C Y .2024 .Assessment of noninvasive brain stimulation interventions in Parkinson's disease: A systematic review and network meta-analysis. Sci. Rep, 14(1) : 14219.
Xie CL,Chen J,Wang XD,Pan JL,Zhou Y,Lin SY,Xue XD,Wang WW .2015 .Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: A meta-analysis of randomized controlled clinical trials. Neurol. Sci., 36(10) : 1751-1761.
Yuan Y,Wu Y,Zhao H,Ren J,Su W,Kou Y,Wang Q,Cheng J,Tong Z J .2013 .Tropospheric formaldehyde levels infer ambient formaldehydeinduced brain diseases and global burden in China,. , 883 : 163553.
0

Citations

0

Downloads

63

Views